arrow
J

Jennifer J. Mueller

Memorial Sloan Kettering Cancer Center
H指数:29
被引数:3,178

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic value of positive peritoneal cytology in FIGO 2009 stage IA grade 1 endometrioid endometrial cancer

FIGO 2009分期标准下,G1级子宫内膜样子宫内膜癌中阳性腹水细胞学的预后价值

2025-10-170
PRE
A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes: A Memorial Sloan Kettering Cancer Center Team Ovary Study

卵巢哨兵淋巴结显像的可行性研究:纪念斯隆-凯特琳癌症中心团队卵巢研究

2025-10-020
PRE
Erratum to ‘Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101651]

勘误:‘实质淋巴血管间隙浸润对手术I期子宫内膜样子宫内膜腺癌首次疾病复发位置的影响’[国际妇科肿瘤杂志 卷35 期4 (2025) 101651]

2025-06-060
PRE
Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytology

子宫内膜癌的腹腔冲洗液分析:比较肿瘤基因突变检测与基因测序板与传统细胞学检查

2025-06-010
PRE
Multi-center, international endometrial cancer consortium highlights

多中心、国际子宫内膜癌联盟重点内容

2025-05-010
PRE
RELEVANT-C study: patient-reported prevalence of lower extremity lymphedema after sentinel lymph node mapping vs lymphadenectomy after surgery for early-stage cervical cancer

RELEVANT-C研究:早期宫颈癌手术后,行前哨淋巴结定位与行淋巴结清扫术后患者报告的下肢淋巴水肿患病率比较

2025-02-010
PRE
Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma

显著淋巴血管间隙浸润对手术期Ⅰ期子宫内膜样子宫内膜腺癌首次疾病复发部位的影响

2025-01-011
PRE
A digital, decentralized trial of exercise therapy in patients with cancer
2024-10-280
OAAI
Oncologic and Perioperative Outcomes of Robot-Assisted Versus Conventional Laparoscopy for the Treatment of Clinically Uterine-Confined High-Grade Adenocarcinoma

机器人辅助与传统腹腔镜治疗临床子宫受限高级别腺癌的肿瘤学和围手术期结果

2024-09-241
PRE
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
2024-04-234
OAAI
Comprehensive analysis of germline drivers in endometrial cancer
2023-02-069
OA